Apollo Endosurgery Inc Valor Contábil/Ação
Qual é o Valor Contábil/Ação de Apollo Endosurgery Inc?
O Valor Contábil/Ação de Apollo Endosurgery Inc é 0.83
Qual é a definição de Valor Contábil/Ação?
O valor contábil por ação é um ativo da empresa menos as responsabilidades dividido pelo número de ações em circulação.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Valor Contábil/Ação de empresas na Setor Health Care em NASDAQ em comparação com Apollo Endosurgery Inc
O que Apollo Endosurgery Inc faz?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Empresas com valor contábil/ação semelhantes a Apollo Endosurgery Inc
- Fast Finance24 AG tem Valor Contábil/Ação de 0.83
- ITM Power Plc tem Valor Contábil/Ação de 0.83
- China Shandong Hi-Speed tem Valor Contábil/Ação de 0.83
- WildBrain tem Valor Contábil/Ação de 0.83
- Chongqing Iron & Steel tem Valor Contábil/Ação de 0.83
- A8 New Media tem Valor Contábil/Ação de 0.83
- Apollo Endosurgery Inc tem Valor Contábil/Ação de 0.83
- ECN Capital tem Valor Contábil/Ação de 0.83
- JD Sports Fashion plc tem Valor Contábil/Ação de 0.83
- COSCO SHIPPING Development Co tem Valor Contábil/Ação de 0.83
- China Eco-Farming tem Valor Contábil/Ação de 0.83
- Gordon Pointe Acquisition tem Valor Contábil/Ação de 0.83
- Concord New tem Valor Contábil/Ação de 0.83